Researchers have discovered that the smooth muscle cells lining the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the disease.

One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria in children in Mali during the country’s six-month malaria season.

Researchers have discovered that choline, an essential nutrient vital for brain health, is actively transported from the bloodstream into the brain by a protein. The findings may inform the development of new drugs that take advantage of this mechanism to treat brain disorders.

A drug used to treat certain bone diseases shows promise for slowing the progression of a rare, painful genetic condition that causes excessive calcium buildup in the arteries, known as arterial calcification due to deficiency of CD73 (ACDC).

A research team led by Dr. Christopher Gibbons of Beth Israel Deaconess Medical Center has been working to identify accessible biomarkers that could help diagnose Parkinson’s disease and other neurodegenerative disorders.

NCI researchers developed an artificial intelligence (AI) tool that uses data from individual cells inside tumors to predict whether a person’s cancer will respond to a specific drug.

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD).

SARS-CoV-2, the virus that causes Covid-19, can damage the heart even without directly infecting the heart tissue.

Fenoprofen, a nonsteroidal anti-inflammatory drug (NSAID), successfully alleviated pain and inflammation in a rodent model of endometriosis.

Approximately 11% of 12th-grade students across the country reported past-year use of delta-8-tetrahydrocannabinol (delta-8-THC, or delta-8 for short), according to an analysis from the 2023 Monitoring the Future survey.